What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Disease
- Gene
Michelle Petri spends much of her time researching Lupus erythematosus, Internal medicine, Immunology, Systemic lupus erythematosus and Connective tissue disease.
The concepts of her Lupus erythematosus study are interwoven with issues in Systemic disease, Belimumab, Prospective cohort study, Severity of illness and Risk factor.
Her studies deal with areas such as Gastroenterology, Placebo and Surgery as well as Internal medicine.
Michelle Petri interconnects Single-nucleotide polymorphism, Genetic association and Epidemiology in the investigation of issues within Immunology.
As part of one scientific family, Michelle Petri deals mainly with the area of Systemic lupus erythematosus, narrowing it down to issues related to the Pregnancy, and often Obstetrics.
Her Connective tissue disease research is multidisciplinary, relying on both Quality of life and Immunopathology.
Her most cited work include:
- Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. (2521 citations)
- The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. (1742 citations)
- The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes (1437 citations)
What are the main themes of her work throughout her whole career to date?
Her primary scientific interests are in Internal medicine, Immunology, Systemic lupus erythematosus, Lupus erythematosus and Cohort.
Her Internal medicine study integrates concerns from other disciplines, such as Gastroenterology and Surgery.
Her study in Disease extends to Immunology with its themes.
Her research in Systemic lupus erythematosus tackles topics such as Lupus anticoagulant which are related to areas like Antiphospholipid syndrome.
Her biological study spans a wide range of topics, including Pregnancy, Clinical trial, Placebo, Physical therapy and Severity of illness.
Her Cohort study incorporates themes from Disease activity, Incidence, Epidemiology, Cohort study and Proportional hazards model.
She most often published in these fields:
- Internal medicine (52.36%)
- Immunology (42.38%)
- Systemic lupus erythematosus (34.28%)
What were the highlights of her more recent work (between 2017-2021)?
- Internal medicine (52.36%)
- Systemic lupus erythematosus (34.28%)
- Cohort (18.35%)
In recent papers she was focusing on the following fields of study:
Michelle Petri mainly focuses on Internal medicine, Systemic lupus erythematosus, Cohort, Hydroxychloroquine and Lupus erythematosus.
Her Internal medicine study frequently links to related topics such as Gastroenterology.
Her Systemic lupus erythematosus research incorporates themes from Disease activity, Cohort study, Autoantibody, Prednisone and Prospective cohort study.
Her work focuses on many connections between Cohort and other disciplines, such as Proportional hazards model, that overlap with her field of interest in Hazard ratio.
As a part of the same scientific family, she mostly works in the field of Lupus erythematosus, focusing on Disease and, on occasion, Transcriptome and Oncology.
Her research investigates the connection between Lupus nephritis and topics such as Immunology that intersect with problems in Cell.
Between 2017 and 2021, her most popular works were:
- Distinct Effector B Cells Induced by Unregulated Toll-like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus Erythematosus (256 citations)
- Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial (209 citations)
- Systemic lupus erythematosus: Diagnosis and clinical management. (126 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Gene
Michelle Petri mainly investigates Internal medicine, Lupus erythematosus, Systemic lupus erythematosus, Clinical trial and Immunology.
As a member of one scientific family, she mostly works in the field of Internal medicine, focusing on Antibody and, on occasion, Gastroenterology, Core laboratory and Mean age.
Her Lupus erythematosus research incorporates elements of Odds ratio, Gene expression profiling, Young adult, Disease and Severity of illness.
In her study, Dermatology and Low Complement is inextricably linked to Disease activity, which falls within the broad field of Systemic lupus erythematosus.
Her Clinical trial research includes themes of Placebo, Antiphospholipid syndrome, Adverse effect and Rash.
Her work on Immunology is being expanded to include thematically relevant topics such as Gene expression.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
